Is Abattis Bioceuticals Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Abattis Bioceuticals Corp (ATTBF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Abattis Bioceuticals Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Abattis Bioceuticals Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Abattis Bioceuticals Corp?

Muslim investors may consider investing in Abattis Bioceuticals Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Abattis Bioceuticals Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Abattis Bioceuticals Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Abattis Bioceuticals Corp updated?

The Shariah compliance status of Abattis Bioceuticals Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Abattis Bioceuticals Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Abattis Bioceuticals Corp?

You can check the latest Shariah compliance status of Abattis Bioceuticals Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Abattis Bioceuticals Corp. Stock Analysis ATTBF

United States Health Care Nano Cap

Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The firm aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. The company operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. The company offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. The company is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

Key Statistics of Abattis Bioceuticals Corp (ATTBF)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

3100.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

478.00

Avg. Volume

47.03K

Dividend Yield

Financial Metrics & Statements of Abattis Bioceuticals Corp (ATTBF)

FAQ's for Abattis Bioceuticals Corp (ATTBF)

According to Musaffa’s Shariah screening methodology, Abattis Bioceuticals Corp (ATTBF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.